SOURCE: GS MEDIA // Issues Volume Alert On (NASDAQ:GLUU), (NASDAQ:USAT), (NASDAQ:STEM), (NASDAQ:JRCC), (NASDAQ:LARK) Is announcing Investment Highlights on Glu Mobile (NASDAQ:GLUU), USA Technologies (NASDAQ:USAT), StemCells (NASDAQ:STEM), James River (NASDAQ:JRCC), Landmark Bancorp (NASDAQ:LARK)

New York, New York, October 13, 2012 -- Glu Mobile Inc.(NASDAQ:GLUU) shares jumped 16.61% to $3.41 in the previous trading session following news that a venture capital firm run by one of the company's directors made a substantial purchase of the mobile game maker's shares, more than doubling its holdings. Additionally, GLUU‘s stock had its “strong-buy” rating restated by equities researchers at Needham & Company in a report issued yesterday. 

Additionally, the company currently expect to report third quarter 2012 revenue results that are consistent with that prior guidance. The company also expect Adjusted EBITDA results to be slightly favorable to the $3.1 million high end of prior guidance. Analysts expect the company to report revenues of $21.39 million for the third-quarter.

Will GLUU Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here

USA Technologies, Inc.(NASDAQ:USAT) shares climbed 10.60% and closed at $1.67 in the last trading session. On October 9, 2012, USA Technologies, Inc. and Visa U.S.A. Inc. entered into a First Amendment to the agreement that had been previously entered into between them on October 12, 2011. Pursuant to the First Amendment, the original one-year term of the Agreement has been extended until October 31, 2013, and will automatically renew for an additional year, or until October 31, 2014, unless either party would provide at least 60-days prior notice of non-renewal. 

How Should Investors Trade USAT After The Recent Momentum, Find Out Here

StemCells, Inc.(NASDAQ:STEM) shares gained 7.92% and closed at $2.18 in the previous trading session after the company announced the issuance of U.S. Patent Number 8,283,164 titled "Liver engrafting cells, assays, and uses thereof." The patent broadly covers purified populations of human liver cells, including the Company's human liver engrafting cells (hLEC).

In October 2011, StemCells formed a wholly-owned subsidiary to focus on both the therapeutic and research tool applications of its hLEC technologies and to serve as an investment vehicle for those interested in a "pure play" liver cell company.

Get Free Special Trend Analysis On STEM Here

James River Coal Company(NASDAQ:JRCC) shares increased 3.74% and closed at $3.88 in yesterday’s session. The Securities Arbitration Law Firm of Klayman & Toskes, P.A. (K&T), last month, announced that it is investigating claims on behalf of James River Coal Co shareholders who sustained investment losses due to an over-concentration of shares in James River Coal Co. stock. Since mid-2008, the price of James River Coal Co. dropped from about $59 per share and is currently trading at about $3.25 per share, representing a decline of approximately 95%

Get Free Special Trend Analysis On JRCC Here

Landmark Bancorp, Inc.(NASDAQ:LARK) stock closed at $20.39 after climbing 3.65% in yesterday’s trading session. The company announced that it will release earnings for the third quarter of 2012 after the market closes on Wednesday, October 31, 2012. The Company will host a conference call to discuss these results on Thursday, November 1, 2012 at 10:00 am (CT).

Get Free Special Trend Analysis On LARK Here

About Beststocksdaily

Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.



Brian Burr


1419 Westwood Blvd Los Angeles, CA